We further verified the expression of TRIM2 and DOCK4 based on RNA-seq data from 5 LUAD patients, which suggested that TRIM2 was up-regulated and DOCK4 was down-regulated in tumor tissues compared with NATs (Figure 5G), which was consistent with the results from the GEPIA2 database (483 tumor and 347 normal samples) (Figure S5E). This evidence concerns the gene TRIM2 and neoplasm.